Burdensome and costly regulations are sucking the life out of our economy. The regulatory regime imposed by unelected czars unfairly punishes small businesses and protects well-connected incumbents from competition. We need to reform regulations in a common sense way that will not hamper growth and punish entrepreneurs.
FreedomWorks Originals provides you entertainment and education to help you better understand economics, the workings of government, and our insight into the most important debates facing our nation today. Watch and subscribe today!
On behalf of FreedomWorks’ activist community, I urge you to contact your representative and ask him or her to vote NO on the Patient Protection and Affordable Care Enhancement Act, H.R. 1425. This bill doubles down on ObamaCare by attempting to force more people into both the exchanges and Medicaid while also adding on socialist-style price controls on prescription drugs. Although Democrats have made clear that Medicare for All remains their policy end-goal, this latest proposal seems to show that they are content in the meantime to continue herding patients into the existing silos that ObamaCare narrowed health care payments into.
Democrats are expected to vote early next week on a bill, H.R. 1425, entitled the “Patient Protection and Affordable Care Enhancement Act.” The bill is exactly what it explicitly claims to be - a doubling down on the original structure of ObamaCare, with some extra patches added in. This is likely a foreshadowing of the push we’ll see to take the next step in expanding government control of health care should Democrats succeed in taking the White House in 2020.
WASHINGTON, D.C. -- In response to the Trump administration’s new executive order (EO) that urges agencies to spur increased investment in infrastructure through deregulation, Adam Brandon, FreedomWorks Foundation President, commented:
WASHINGTON, D.C. -- In response to the Bureau of Labor Statistics (BLS) release of the latest employment data for May 2020 showing a drop in unemployment from from 14.7 percent to 13.3 percent, Adam Brandon, FreedomWorks Foundation President, commented:
WASHINGTON, D.C. -- In response to the Environmental Protection Agency’s (EPA) proposal to mandate transparent cost-benefit analyses for significant regulations promulgated under the Clean Air Act, Adam Brandon, FreedomWorks Foundation President, commented:
FreedomWorks recently announced the launch of the American Freedom Initiative (AFI), a collaboration headed by former acting U.S. Attorney General Matt Whitaker. This project aims to help relieve injustices committed against Americans under the criminal justice system and the regulatory state. As part of this project, we will shine a spotlight on some of the individuals the AFI has identified under its Administrative Abuse Project who have been the victims of federal regulatory overreach.
WASHINGTON, D.C. -- In response to President Trump’s executive order today directing agency heads to remove burdensome regulations that hamper economic recovery from COVID-19, Adam Brandon, FreedomWorks’ President, commented:
Famed investor and liberal political activist Bradley Tusk raised eyebrows with what he and many on the left dubbed provocative: a defense of “Big Pharma” in the U.S. The premise is straightforward: for the medical community to conduct the type of R&D required to combat challenges like coronavirus, they cannot be subject to strict price control regimes so popular among progressives.
WASHINGTON, D.C. -- After announcing Rep. Mike Johnson (R-La.) as FreedomWorks’ Member of the Month for May 2020 and the VITAL Act, S. 3512, as FreedomWorks’ Bill of the Month for May 2020, Jason Pye, FreedomWorks Vice President of Legislative Affairs, commented:
